102 related articles for article (PubMed ID: 3034846)
21. K-13, a novel inhibitor of angiotensin I converting enzyme produced by Micromonospora halophytica subsp. exilisia. II. Structure determination.
Yasuzawa T; Shirahata K; Sano H
J Antibiot (Tokyo); 1987 Apr; 40(4):455-8. PubMed ID: 3034845
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibitors: synthesis and structure-activity relationships of potent N-benzyloxycarbonyl tripeptide inhibitors.
Sawayama T; Tsukamoto M; Sasagawa T; Nishimura K; Yamamoto R; Deguchi T; Takeyama K; Hosoki K
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2417-22. PubMed ID: 2605684
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological activity of pentapeptide analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline.
Almquist RG; Jennings-White C; Chao WR; Steeger T; Wheeler K; Rogers J; Mitoma C
J Med Chem; 1985 Aug; 28(8):1062-6. PubMed ID: 2991517
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Kajiwara Y; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid.
Johnson AL; Price WA; Wong PC; Vavala RF; Stump JM
J Med Chem; 1985 Nov; 28(11):1596-602. PubMed ID: 2999393
[TBL] [Abstract][Full Text] [Related]
26. Induction of angiotensin-converting enzyme with the ACE inhibitory compound MK-421 in rat lung.
Forslund T; Fyhrquist F; Grönhagen-Riska C; Tikkanen I
Eur J Pharmacol; 1982 May; 80(1):121-5. PubMed ID: 6284528
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with omega-(4-piperidyl)alkyl group.
Waga T; Matsui S; Saito S; Watanabe M; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 Apr; 40(4):407-13. PubMed ID: 2162675
[TBL] [Abstract][Full Text] [Related]
28. Total serum angiotensin converting enzyme activity in rats and dogs after enalapril maleate (MK-421).
Ulm EH; Vassil TC
Life Sci; 1982 Apr; 30(14):1225-30. PubMed ID: 6283285
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
Laubie M; Schiavi P; Vincent M; Schmitt H
J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of N-(phosphonoacetyl)-dipeptide derivatives and evaluation of their antihypertensive activity.
Osapay G; Körmöczy P; Szilágyi I; Kajtár J; Kiss B
Pharmazie; 1990 Sep; 45(9):666-8. PubMed ID: 2178265
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acids derivatives.
Gruenfeld N; Stanton JL; Yuan AM; Ebetino FH; Browne LJ; Gude C; Huebner CF
J Med Chem; 1983 Sep; 26(9):1277-82. PubMed ID: 6310113
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
Wilkes BM
J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
[TBL] [Abstract][Full Text] [Related]
33. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
[TBL] [Abstract][Full Text] [Related]
34. Studies on WF-3681, a novel aldose reductase inhibitor. I. Taxonomy, fermentation, isolation and characterization.
Nishikawa M; Tsurumi Y; Namiki T; Yoshida K; Okuhara M
J Antibiot (Tokyo); 1987 Oct; 40(10):1394-9. PubMed ID: 3119547
[TBL] [Abstract][Full Text] [Related]
35. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
Chatelain RE; Ghai RD; Trapani AJ; Odorico LM; Dardik BN; De Lombaert S; Lappe RW; Fink CA
J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
[TBL] [Abstract][Full Text] [Related]
36. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Takata Y; Di Nicolantonio R; Hutchinson JS
Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives.
Stanton JL; Gruenfeld N; Babiarz JE; Ackerman MH; Friedmann RC; Yuan AM; Macchia W
J Med Chem; 1983 Sep; 26(9):1267-77. PubMed ID: 6310112
[TBL] [Abstract][Full Text] [Related]
38. Protonated amino acid precursor studies on rhodotorulic acid biosynthesis in deuterium oxide media.
Akers HA; Llinás M; Neilands JB
Biochemistry; 1972 Jun; 11(12):2283-91. PubMed ID: 5063738
[No Abstract] [Full Text] [Related]
39. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline.
Almquist RG; Chao WR; Jennings-White C
J Med Chem; 1985 Aug; 28(8):1067-71. PubMed ID: 2991518
[TBL] [Abstract][Full Text] [Related]
40. Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.
Minsker DH; Bagdon WJ; Robertson RT; Bokelman DL
J Toxicol Environ Health; 1984; 14(5-6):715-22. PubMed ID: 6097696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
